Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 12/20 | 0.61 |
| ▸ | MME | P08473 | 7/20 | 0.60 |
| ▸ | CPA1 | P15085 | 5/20 | 0.60 |
| ▸ | ACE2 | Q9BYF1 | 5/20 | 0.60 |
| ▸ | ANPEP | P15144 | 2/20 | 0.55 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.55 |
| ▸ | CTSD | P07339 | 1/20 | 0.54 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32889357 | 0.94 | ACE (0.62) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL30051899 | 0.92 | ACE (0.65) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL30541918 | 0.90 | ACE (0.62) | ACEMMECPA1ACE2 | |
| SCHEMBL29351159 | 0.90 | ACE (0.60) | ACEMMECPA1ACE2ANPEP | |
| SCHEMBL25626025 | 0.88 | ACE (0.60) | ACEMMECPA1ACE2ANPEP | |
| SCHEMBL29876711 | 0.88 | ACE (0.58) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL30799266 | 0.87 | CTSD (0.56) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL34467263 | 0.87 | ACE (0.61) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL7678279 | 0.87 | ACE (0.65) | ACEMMECPA1ACE2ANPEP | |
| SCHEMBL29405922 | 0.87 | CTSD (0.61) | ACEMMECPA1ACE2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115651068-A | Cyclo-C-casein-isoleucin-phenylpropanoid with hepatoma carcinoma cytotoxicity and alpha-glucosidase inhibition activity and preparation method thereof | 安徽农业大学 | 2023-01-31 | — | — | CN | disclosed |